NLRP3 and Parkinson disease: In vitro models have proven that soluble antibody-α-syn complexes further neurotoxicity by activating NLRP3 inflammasomes in microglia [68], thereby implicating antibodies and, in turn, B cell involvement within neuroinflammatory cascades in PD.